Ortikos, an anti-inflammatory corticosteroid, is approved as a once-daily treatment for mild to moderate active Crohn disease and for maintenance of clinical remission. Ferring Pharmaceuticals ...

The FDA granted accelerated approval for the first drug to reduce proteinuria in primary immunoglobulin A (IgA) nephropathy, the agency announced on Wednesday. The delayed released budesonide (Tarpeyo ...

WASHINGTON -- Once-daily budesonide in gastro-resistant capsule form (Budenofalk) showed promise as an oral treatment for lymphocytic colitis, a manufacturer-sponsored phase III study demonstrated. At ...

Systemic corticosteroids, such as prednisolone, are linked to OSTEOPOROSIS in patients with Crohn's disease. In controlled-release (CR) capsule form, budesonide is a locally acting corticosteroid with ...

Budesonide is recommended as one of the first-line drugs for treatment of eosinophilic esophagitis (EoE), a chronic immune-mediated inflammatory disease, and in a recent study researchers updated a ...

Agreement follows ex-US divestment of Entocort in July 2015 23 November 2015 - AstraZeneca today announced that it has entered into an agreement with Perrigo Company plc for the divestment of US ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Inhaled budesonide twice daily administered early in the ...

This action formally initiates the patent challenge process under the Hatch-Waxman Act. Entocort EC (budesonide) had annual sales of approximately $125 million in the U.S., based on IMS sales data for ...

Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...

JERUSALEM Teva Pharmaceutical Industries and AstraZeneca have reached a settlement that will allow Teva to market its generic version of a drug for treating Crohn’s disease, the Israeli generic drug ...

Background An adolescent boy aged 17 years presented with sudden onset of visual impairment, which was rapidly diagnosed as bilateral anterior uveitis by an ophthalmologist. A systemic review noted ...